Nektar Therapeutics Insider Transactions
Nektar Therapeutics Insider Trades History
Insider Name | Buy/Sell | Shares Bought/Sold @ Price |
Total Transaction | Shares Held After Transaction |
Transaction Date | Filing Date | Details |
---|---|---|---|---|---|---|---|
Zalevsky Jonathan
Chief R&D Officer |
Sell | 51,115 @ $0.94 | $48,048 | 326,904 | 12/19/2024 | 12/20/2024 | |
ROBIN HOWARD W
CEO |
Sell | 85,035 @ $0.99 | $84,185 | 1,110,675 | 12/18/2024 | 12/19/2024 | |
ROBIN HOWARD W
CEO |
Sell | 46,995 @ $1.01 | $47,465 | 1,195,710 | 12/17/2024 | 12/19/2024 | |
Zalevsky Jonathan
Chief R&D Officer |
Sell | 7,785 @ $1.01 | $7,863 | 243,019 | 11/19/2024 | 11/20/2024 | |
Wilson Mark Andrew
Chief Legal Officer |
Sell | 6,407 @ $1.01 | $6,471 | 218,856 | 11/19/2024 | 11/20/2024 | |
ROBIN HOWARD W
CEO |
Sell | 16,278 @ $1.01 | $16,441 | 832,080 | 11/19/2024 | 11/20/2024 | |
Zalevsky Jonathan
Chief R&D Officer |
Sell | 6,866 @ $1.28 | $8,788 | 250,804 | 08/19/2024 | 08/20/2024 | |
Wilson Mark Andrew
Chief Legal Officer |
Sell | 5,651 @ $1.28 | $7,233 | 225,263 | 08/19/2024 | 08/20/2024 | |
ROBIN HOWARD W
CEO |
Sell | 14,881 @ $1.28 | $19,048 | 848,358 | 08/19/2024 | 08/20/2024 | |
CHESS ROBERT
Director |
Sell | 19,500 @ $1.20 | $23,400 | 255,273 | 06/14/2024 | 06/14/2024 | |
ROBIN HOWARD W
CEO |
Sell | 16,650 @ $1.75 | $29,138 | 863,239 | 05/17/2024 | 05/20/2024 | |
Wilson Mark Andrew
Chief Legal Officer |
Sell | 6,260 @ $1.75 | $10,955 | 230,414 | 05/17/2024 | 05/20/2024 | |
Zalevsky Jonathan
Chief R&D Officer |
Sell | 7,355 @ $1.75 | $12,871 | 257,670 | 05/17/2024 | 05/20/2024 | |
Deep Track Capital, LP
10 percent owner |
Sell | 56,000 @ $1.78 | $99,630 | 18,344,000 | 05/10/2024 | 05/13/2024 | |
Zalevsky Jonathan
Chief R&D Officer |
Sell | 9,014 @ $0.68 | $6,130 | 265,025 | 02/20/2024 | 02/22/2024 | |
Wilson Mark Andrew
Chief Legal Officer |
Sell | 7,606 @ $0.68 | $5,172 | 236,674 | 02/20/2024 | 02/22/2024 | |
ROBIN HOWARD W
CEO |
Sell | 20,033 @ $0.68 | $13,622 | 879,889 | 02/20/2024 | 02/22/2024 | |
Zalevsky Jonathan
Chief R&D Officer |
Sell | 9,646 @ $0.49 | $4,727 | 274,039 | 11/17/2023 | 11/20/2023 | |
Wilson Mark Andrew
Chief Legal Officer |
Sell | 7,179 @ $0.49 | $3,518 | 243,780 | 11/17/2023 | 11/20/2023 | |
ROBIN HOWARD W
CEO |
Sell | 19,877 @ $0.49 | $9,740 | 899,922 | 11/17/2023 | 11/20/2023 |
Nektar Therapeutics FAQ's
The list of insiders at Nektar Therapeutics includes ROBIN HOWARD W, Wilson Mark Andrew, Zalevsky Jonathan, Deep Track Capital, LP, CHESS ROBERT.
Insiders have sold a total of 383,431 Nektar Therapeutics shares in the last 12 months for a total of 446,459 sold.
The following insiders have sold Nektar Therapeutics shares in the last 12 months: ROBIN HOWARD W ($209,898), Wilson Mark Andrew ($29,831), Zalevsky Jonathan ($83,700), Deep Track Capital, LP ($99,630), CHESS ROBERT ($23,400),